Publication:
The Effects of COVID-19 lockdown on neuropsychiatric symptoms in patients with dementia or mild cognitive impairment: A systematic review and meta-analysis.

dc.contributor.authorSoysal, PINAR
dc.contributor.authorSmith, Lee
dc.contributor.authorTrott, Mike
dc.contributor.authorAlexopoulos, Panagiotis
dc.contributor.authorBarbagallo, Mario
dc.contributor.authorTan, Semen Gokce
dc.contributor.authorKoyanagi, Ai
dc.contributor.authorShenkin, Susan
dc.contributor.authorVeronese, Nicola
dc.contributor.institutionauthorSOYSAL, PINAR
dc.date.accessioned2022-02-08T20:59:14Z
dc.date.available2022-02-08T20:59:14Z
dc.date.issued2022-02-06T00:00:00Z
dc.description.abstractThe COVID-19 pandemic may have a disproportionate impact on people with dementia/mild cognitive impairment (MCI) due to isolation and loss of services. The aim of this systematic review was to investigate the effects of the COVID-19 lockdown on neuropsychiatric symptoms (NPS) in people living with dementia/MCI. Two authors searched major electronic databases from inception to June 2021 for observational studies investigating COVID-19 and NPS in people with dementia/MCI. Summary estimates of mean differences in NPS scores pre- versus post-COVID-19 were calculated using a random-effects model, weighting cases using inverse variance. Study quality and risk of bias were assessed by the Newcastle-Ottawa Scale. From 2730 citations, 21 studies including 7139 patients (60.0% female, mean age 75.6 ± 7.9 years, 4.0% MCI) with dementia were evaluated in the review. Five studies found no changes in NPS, but in all other studies, an increase in at least one NPS or the pre-pandemic Neuropsychiatric Inventory (NPI) score was found. The most common aggravated NPS were depression, anxiety, agitation, irritability, and apathy during lockdown, but 66.7% of the studies had a high bias. Seven studies including 420 patients (22.1% MCI) yielded enough data to be included in the meta-analysis. The mean follow-up time was 5.9 ± 1.5 weeks. The pooled increase in NPI score before compared to during COVID-19 was 3.85 (95% CI:0.43 to 7.27; P = 0.03; I2 = 82.4%). All studies had high risk of bias. These results were characterized by high heterogeneity, but there was no presence of publication bias. There is an increase in the worsening of NPS in people living with dementia/MCI during lockdown in the COVID pandemic. Future comparative studies are needed to elucidate whether a similar deterioration might occur in people without dementia/MCI.
dc.identifier.doi10.1111/psyg.12810
dc.identifier.pubmed35128762
dc.identifier.urihttp://hdl.handle.net/20.500.12645/30380
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCOVID-19
dc.subjectdementia
dc.subjectmild cognitive impairment neuropsychiatric symptoms
dc.titleThe Effects of COVID-19 lockdown on neuropsychiatric symptoms in patients with dementia or mild cognitive impairment: A systematic review and meta-analysis.
dc.typeArticle
dspace.entity.typePublication
local.avesis.id6be0325d-fc56-4e2d-af09-2861aa202d32
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isAuthorOfPublication0e36986e-d71d-4579-a395-877af097ade5
relation.isAuthorOfPublication.latestForDiscovery0e36986e-d71d-4579-a395-877af097ade5
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
The Effects of COVID 19 lockdown on neuropsychiatric symptoms in patients with dementia or mild cognitive impairment A systematic review and meta analysis.pdf
Size:
1.16 MB
Format:
Adobe Portable Document Format
Description: